Mammalian Cell Cultures for Biologics Manufacturing
Biopharmaceuticals represent a growing sector of the pharmaceutical industry, and are used for a wide range of indications, including oncology and rheumatology. Cultured mammalian cells have become the predominant expression system for their production, partly due to their ability to complete the posttranslational modifications required for drug safety and efficacy. Over the past decade, the productivity of mammalian cell culture production processes has growth dramatically through improvements in both volumetric and specific productivities. This article presents an overview of the biologics market, including analysis of sales and approvals; as well as a review of industrial production cell lines and cell culture operations.
KeywordsBiopharmaceuticals Cell culture operations Mammalian cell culture Production cell lines
- 1.Aggarwal S (Rob) (2012) What’s fueling the biotech engine—2011 to 2012. Nat Biotechnol 30(12):1191–1197Google Scholar
- 2.Aggarwal S (Rob) (2007) What’s fueling the biotech engine? Nat Biotechnol 25(10):1097–1104Google Scholar
- 4.Kim JY, Kim Y-G, Lee GM (2012) CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microb Biotechnol 93:917–930Google Scholar
- 6.La Merie Business Intelligence (2013) Blockbuster Biologics 2012. R&D Pipeline News, May 7 2013, Special Edition 1Google Scholar